May 13 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2020 Mar 31, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 18 mln 334 mln
(-100.0 pct) (+96.8 pct)
Operating loss 305 mln loss 479 mln loss 1.09
Recurring loss 307 mln loss 484 mln loss 1.09
Net loss 302 mln loss 467 mln loss 1.09
EPS loss 20.93 yen loss 45.01 yen loss 71.74 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T